Abstract This study aimed to explore the relationship of body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) with cognition in women with (HIV+) and without HIV (HIV−) infection. One thousand six hundred ninety participants (1,196 HIV+, 
Introduction
Human immunodeficiency virus (HIV) infection is one of the most prevalent infectious diseases worldwide. Since survival of those with HIV infection is extended because of adherence to antiretroviral therapies, HIV infection will become a chronic infection of aging.
According to the CDC, in 2010 there were an estimated 47,500 people newly infected with HIV in the United States. Of these, 15 % (N =7,125) were aged 45-55 years and 5 % (n =2,375) were aged 55 years and older (Centers for Disease Control and Prevention 2012a). Add to this, prevalent infections in 2009, there were 381,000 prevalent HIV infections among those aged 45-54 years, and almost 200,000 prevalent HIV infections among those aged 55 years and older (Centers for Disease Control and Prevention 2012b). This totals almost 600,000 HIV-infected adults aged 45 years or older in the USA, which is an underestimate. Thus, these data illustrate the potential burden of HIV-associated cognitive disorders due to the high proportion of HIV/AIDS survivors over age 45 years.
In many countries, the advent of antiretroviral therapy (ART) has been accompanied by an increase in body mass index (BMI) due to normalization of health that also mirrors trends in the general population. However, women enrolled in the Women's Interagency HIV Study (WIHS) women are overweight and obese on average, and overweight and obesity are leading causes of disability and death in the United States and around the world and have been linked to cognitive impairments. Obesity is associated with hypertension, dyslipidemias, type 2 diabetes mellitus, and cardiovascular disease, and these metabolic complications may be more prevalent in HIV (2006; Sobieszczyk et al. 2008) . These factors also increase risk for age-related, late-onset cognitive impairments (CI), and eventually clinical Alzheimer's disease (AD) and vascular dementias (Gustafson and Skoog 2009) Given the aging HIV-infected population, it is important to understand how HIV infection influences aging, as well as accompanying morbidities such as obesity and outcomes such as cognitive impairments and dementia.
Obesity is associated with age-related cognitive impairments and dementia in populations without HIV. Mid-life obesity, estimated using BMI, waist circumference (WC), or waist-to-hip ratio (WHR), measured decades before dementia onset has been linked to higher risk of Alzheimer's Disease (AD) (Fitzpatrick et al. 2009; Gustafson et al. 2009a; Whitmer et al. 2007 ). However, associations of obesity with cognitive impairments in mid-life are unclear (Gustafson et al. 2009a) . It has been suggested that the aging HIV population may experience more than the anticipated burden of cognitive impairments since many HIV-infected individuals have experienced metabolic and vascular consequences of early ART regimens and other medications, in addition to earlier, mid-life cognitive impairments due to the HIV infection. While use of ART has been suggested to decrease the incidence and prevalence of AIDS-or HIV-associated dementias (Berger and Brew 2005; Bhaskaran et al. 2008; González-Scarano and Martín'García 2005; Moroni and Antinoria 2003; Saktor 2002) , the frequency of cognitive impairments has not changed (Heaton et al. 2011) . The impact of HIV, multi-morbidities, and ART on late life sporadic dementias and AD (incident after age 65 years) remains to be understood. Some studies suggest that the prevalence of cognitive impairments, ranging from 15 to 50 %, will worsen as the HIV population ages, thus putting them at risk for AD (Cohen and Gongvatana 2010; Heaton et al. 2010; McArthur and Brew 2010) .
In the present study, we determined whether anthropometric indices are differentially associated with cognitive performance in women who are HIV+ or HIV− from the WIHS (Bacon et al. 2005; Barkan et al. 1998) . Demographic, cardiovascular, and HIV-related factors were considered as confounders.
Methods
The WIHS (Bacon et al. 2005 ) is an ongoing prospective study of HIV in women. The WIHS began in 1994 and enrolled 3,766 women across six sites in San Francisco, Los Angeles, Chicago, Washington, DC, Brooklyn, and the Bronx (New York). WIHS initially recruited 2,054 HIV-infected (HIV+) and 569 HIV-uninfected (who in WIHS, are their 'at risk' counterparts, HIV−) women in 1994 -1995 , and an additional 737 HIV-infected and 406 HIV-uninfected women in 2001 -2002 . Participants are evaluated every 6 months with an extensive interview that includes history of interval illnesses and interval substance abuse, current medications, and medication adherence, physical exam, and blood and gynecological specimen collection.
Demographic measures All demographic measures were selfreported. Race (Bacon et al. 2005; Barkan et al. 1998 ) was self-reported as White, Hispanic, African-American, or 'other' (self-reported as Native American/Alaskan, Asian/ Pacific Islander, or other) for all participants. Participants are also asked to report their current smoking status, and use of marijuana, 'crack', cocaine, and heroin.
Clinical measures Anthropometric measures were conducted according to NHANES III protocol and included body weight (pounds), body height (inches), waist and hip circumferences (cm), and BMI (kg/m 2 ) . Anthropometric measurements were conducted with participants wearing only undergarments. Those who conduct the measurements are recertified every 2 years. Body weight was recorded to the nearest 1.0 pound, and body height was measured to the nearest 1.0 inch. After conversion of body weight and height to metric units, body mass index was calculated as kilograms per meter squared (kg/m 2 ). Categories of BMI used to denote total body adiposity were ≥25 kg/m 2 for overweight and obesity, and ≥30 kg/m 2 for obesity (1989) . Waist and hip circumferences were measured to the nearest 0.5 cm. WHR was calculated as the ratio of waist to hip circumference. Central obesity was defined as WHR>0.80 or WC≥88 cm (Croft et al. 1995) .
Eight-hour fasted blood samples were collected and total cholesterol levels were determined as previously described (Crystal et al. 2011) . Systolic (SBP) and diastolic blood pressures (DBP) were recorded using a standardized protocol (Mansoor et al. 2009 ). Hypertension was defined as either average measured systolic BP >140 mm Hg, or diastolic BP >90 mm Hg, or a self-reported hypertension with use of antihypertensive medications. Previous myocardial infarction (MI) and diabetes mellitus (DM) were self-reported (Bacon et al. 2005; Barkan et al. 1998) .
HIV-related variables Methods for determining HIV status, AIDS diagnosis, CD4 count, viral load, and duration of ART use were described previously (Bacon et al. 2005; Barkan et al. 1998; Kaplan et al. 2008) . (Table 1 ). These tests have been previously described (Crystal et al. 2011) , and were selected for a number of reasons. Most importantly, these tests overlap with those that had already been used for several years in the Men's AIDS Cooperative Study (MACS) (Miller et al. 1990) , which is a "brother" study to the WIHS. In addition, these tests are sensitive to the domains most affected in HIV in the pre-ART era, are relatively short, can be administered reliably by trained personnel who are not neuropsychologists, are less sensitive to practice effects than many other cognitive tests, and cover a number of important cognitive domains shown to be affected early in late-onset AD, in addition to being sensitive to HIV-associated neurocognitive disorder (HAND). Among participants who completed testing on multiple visits, and therefore have more than one score, only the first score was used. Times greater than 240 s were coded as 240 s. Errors were recorded, but were not used to adjust interference times. For all cognitive tests, we used raw scores rather than normalized data.
Inclusion criteria
We include all data collected by visit 28, concluding in September 2008 on 1,690 participants (494 uninfected and 1, 196 HIV infected) with data available on both anthropometric and cognitive measures.
Statistical analysis Anthropometric factors were considered as continuous and categorical variables according to commonly defined cutpoints (aforementioned). BMI, WHR, and WC were categorized into tertiles to assist in understanding nonlinear relationships between the anthropometric measures and cognitive test scores, and to practically apply the results to commonly used overweight and obese categories. Linear regression analyses were used to examine the association between the continuous or categorical anthropometric factors and cognitive test scores (time to completion) of Trails A, Trails B, Stroop interference, Stroop color naming, and Stroop word recall; or SDMT score. A longer time to completion (higher score) indicates worse cognitive performance for the first six tests; in contrast, a lower SDMT score denotes worse performance. Regression models were run separately for HIV+ and HIV−. Several covariates were considered, including: age, race, highest educational level attained, Wide Range Achievement Test (WRAT) score, HIV status, ART, CD4 count, CD4 nadir, prevalent DM, SBP, DBP, use of anti-hypertensive medications, use of exogenous insulin, blood cholesterol level, current smoking status, and use of marijuana, 'crack', cocaine, and/or heroin. Potential covariates were included if significant in age-adjusted models at a level of p <0.05. Given Table 2 Demographic and health characteristics of Women's Interagency HIV Study (WIHS) participants with anthropometric measurements 
Results
Both anthropometric factors and cognition were available for 1,664 WIHS participants (1, . Demographic, anthropometric, and health characteristics are presented in Table 2 . Notably, based on average age, these women were not at risk for late-onset, aging-related cognitive impairments or dementias. HIV+ women were approximately 4 years older than HIV− women, however educational attainment, a key influencer of cognitive performance, did not differ between HIV+ and HIV− women. In addition, most (69 %) women were overweight or obese (≥25.0 kg/m 2 ) and the prevalence of central obesity was high. There was a very low percentage of women with BMI<18.5, in concordance with the low prevalence of AIDS among those who were HIV+. HIV+ women had lower average BMI and WC, and higher WHR, compared to HIV− women. Among published vascular risk factors for dementia, hypertension was also more prevalent in HIV+ women; however, average total blood cholesterol levels and the prevalence of diabetes mellitus did not differ.
Multivariate linear regression analyses relating anthropometric measures to cognitive test scores showed divergent results by test and anthropometric measure. It is important to note that the covariates included in the final multivariate models are those that were significant in age-adjusted models. Variables associated with HIV disease and typically included in models of HIV, such as CD4 count, are not included in final models since they were not significantly associated in ageadjusted models.
Body mass index, BMI (Table 3 , an obese BMI (30 kg/m 2 or higher), and an increasing continuous BMI were related to shorter Trails B completion time (better performance), and longer time to Stroop interference test completion (worse performance), both executive function measures. A BMI<18.5 kg/m 2 was associated with lower SDMT score, a measure of psychomotor speed, and evidence of worse performance. Among HIV− Waist circumference (Table 4 ) Among women with HIV, a waist circumference of 88 cm or more was related to shorter completion time on Trails B (better performance); and a nonlinear relation with Trails A, such that the shortest time to completion (best performance) was observed among those in the middle category of waist circumference (80-87.9 cm). Among HIV− women, there were no associations between waist circumference and performance on any test after adjusting for potential confounders.
Waist-to-hip ratio, WHR (Table 5 ) Among women with HIV, a higher WHR was associated with a better SDMT score. However, there were no other associations between WHR and cognitive performance in HIV+ or HIV− women.
Subanalyses In subsequent analyses, ART use was evaluated as a potential confounder in multivariate models predicting cognitive test scores. Use versus no use of ART was not found to influence the results. Over 80 % of participants were on ART. Similarly, we excluded women who reported recent use of recreational drugs and the results were similar in all essential aspects.
Discussion
Among women at mid-life with HIV for at least 10 years, the association between common anthropometric measures (primarily BMI) and cognitive test performance differed depending on the cognitive domain being assessed. Perhaps these observations illustrate the severity and variable metabolic dysregulation in women with HIV. Considering any anthropometric measure-BMI, WC, or WHR-in relation to cognition, we observed some patterns in women with HIV infection. There appears to be an association between higher BMI and better performance on the Trails B test, and the SDMT. At a significance level of p <0.10, an obese phenotype based on BMI or WC was associated with longer Stroop interference time, yet higher SDMT score. Considering all observed associations, aside from Trails B and SDMT, being more overweight and obese was related to worse performance.
Similar to other reports in non-HIV samples that relate anthropometric measures to cognition, anthropometric measures of being overweight and obese are related to worse cognitive performance. Executive function and speed of information processing are the cognitive domains most commonly associated with these measures.
The association between anthropometric measures and cognitive performance was more pronounced among HIV+ women than HIV− women. Among women in whom higher BMI and WC measures were related to better cognitive function, it may be indicative of a normalization of health due to HIV treatments and better medical and nutritional care and status, for which higher BMI and central obesity may be markers. Among HIV+ women with a BMI<18.5 kg/m 2 , longer completion times on Trails A and B may be due to the detrimental influence of HIV-related illness, such as AIDS or cancer, on cognition, and/or lack of adherence to ART over time. Attempting to evaluate individuals with AIDS as a group was difficult due to a low number of participants; and adjustment for HIV disease markers was not informative.
While high mid-life BMI (Fitzpatrick et al. 2009; Kivipelto et al. 2005; Whitmer et al. 2005) and central obesity (measured as waist circumference or WHR) (Gustafson et al. 2009b; Whitmer et al. 2008) have been shown to increase risk for AD in non-HIV-infected populations, cross-sectional relationships with cognition in mid-life are not clear. In addition, these simple anthropometric measures reflect different aspects of body composition, and are crude estimates of body adiposity at best. A high BMI is reasonably correlated with whole body amount of adipose tissue in healthy HIV-negative adults (Shah and Braverman 2012) . A high waist circumference is a measure of central obesity. However, a high WHR may reflect both higher waist circumference and/or lower hip circumference. In HIV+ individuals who experience lipoatrophy of the hip region, a higher WHR may be more reflective of the lipoatrophy than the central obesity. Thus, these HIV-associated alterations in anthropometric measurements may increase the variability in the measure making it a less accurate measure when compared to an uninfected population. High BMI and WC during mid-life are also related to other vascular risk factors, such as diabetes (Capeau et al. 2012) , hypertension, and hyperlipidemia, which increase risk for cognitive impairments and dementia in non-HIV populations. Hypertension was more prevalent in HIV+ women in this sample compared to HIV− women. However, adjustment for hypertension and insulin resistance did not alter the association of anthropometric factors with cognition in multivariate models. In HIV+ individuals, mid-life relationships of vascular risk factors and cognition are also unclear. The relationship between mid-life risks and late-life cognitive impairment is not known, but will be investigated when this cohort of women enters later stages of life.
At least one other study has investigated the relationship of anthropometric variables on cognitive function in HIV (McCutchan et al. 2012) . Similar results for BMI in relation to cognitive impairment were reported among 130 participants in the CHARTER study (McCutchan et al. 2012 ). Higher BMI (Wright et al. 2010) . Hypertension has also been reported to adversely influence cognition in WIHS (Crystal et al. 2011) . The influence of ART on cognition and overall health in HIV is mixed depending on the severity cognitive outcome being assessed and age of the patient. Data suggest no difference in the proportion of individuals with HIV-associated cognitive disorder in the pre-versus post-ART eras (Heaton et al. 2011) ; however, the prevalence of AIDS dementias, the most severe form of impairment, has fallen precipitously concurrent with optimization of medication regimens and better care overall. As HIV-infected populations survive to older ages, they may be at risk for more severe cognitive impairments. This would be a new phenomenon, but is speculative at this time. ART may have cardiovascular side effects, such as atherosclerosis (Bozzette et al. 2003; Currier 2007) , DM, and hypertension, even in children. These cardiovascular factors have been related to AD in populations without HIV infection; and cardiovascular risk factors are associated with worse cognition in persons with HIV (Becker et al. 2009; Wright et al. 2010) . While the positive influence of ART on cognition is clear, there are several studies that provide controversial data to suggest a concurrent negative influence. Some studies show that discontinuing ART is associated with improved performance on cognitive tests (Mary-Krause et al. 2003; Robertson et al. 2010) , and it has been speculated that certain ART regimens are deleterious for cognition (Andrieu et al. 2011 ). Alternatively, ART has shown a positive effect on health, eliminating HIV and improving health status. Even so, alterations in adipose tissue, adipose tissue distribution, adipose tissue hormones, and/or lipid metabolism, may create an altered metabolic and hormonal milieu that may be undesirable for the brain (Gustafson 2010) . This is a large study of anthropometric measures and cognition in women with and without HIV infection. Strengths include the large multi-ethnic participant sample, and a variety of anthropometric measures that are commonly used to estimate total and regional body fatness. The primary limitations include a limited battery of cognitive tests and cross-sectional analyses. Due to multiple comparisons, and relatively high p values one must also consider risk for false discoveries. Only three p values were <0.005, all among HIVinfected women. These included BMI<18.5 kg/m 2 being associated with worse Trails A and worse SDMT performance, and waist ≥88 cm associated with better Trails B performance. Our analyses were not adjusted for multiple comparisons. However, this is one of the first reports of a consistently reported risk factor for late-onset AD in relation to cognition in HIV. In summary, these data suggest the need for continued follow-up of these women to determine mid-life and late-life effects of adipose tissue and adipose tissue alterations on cognition and dementia in HIV.
